Tradewinds Capital Management’s Gilead Sciences GILD Stock Holding History

Tradewinds Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.05K	Hold	40	–	–	﹤0.01%	469
2026 Q1	$5.58K	Hold	40	–	–	﹤0.01%	450
2025 Q4	$4.91K	Hold	40	–	–	﹤0.01%	454
2025 Q3	$4.44K	Hold	40	–	–	﹤0.01%	448
2025 Q2	$4.43K	Hold	40	–	–	﹤0.01%	417
2025 Q1	$4.48K	Sell	40 -150	-79%	-$15.5K	﹤0.01%	429
2024 Q4	$17.6K	Hold	190	–	–	﹤0.01%	305
2024 Q3	$15.9K	Hold	190	–	–	﹤0.01%	297
2024 Q2	$13K	Hold	190	–	–	﹤0.01%	307
2024 Q1	$13.9K	Hold	190	–	–	﹤0.01%	276
2023 Q4	$15.4K	Hold	190	–	–	0.01%	216
2023 Q3	$14.2K	Hold	190	–	–	﹤0.01%	211
2023 Q2	$14.6K	Hold	190	–	–	﹤0.01%	203
2023 Q1	$15.8K	Sell	190 -89	-32%	-$7.37K	0.01%	200
2022 Q4	$24K	Buy	279 +89	+47%	+$7.05K	0.01%	145
2022 Q3	$12K	Hold	190	–	–	﹤0.01%	195
2022 Q2	$12K	Sell	190 -170	-47%	-$10.5K	﹤0.01%	197
2022 Q1	$21K	Buy	360 +70	+24%	+$4.47K	﹤0.01%	360
2021 Q4	$21K	Sell	290 -200	-41%	-$13.8K	﹤0.01%	369
2021 Q3	$34K	Hold	490	–	–	0.01%	295
2021 Q2	$34K	Buy	490 +140	+40%	+$9.35K	0.01%	300
2021 Q1	$23K	Hold	350	–	–	﹤0.01%	328
2020 Q4	$20K	Hold	350	–	–	﹤0.01%	325
2020 Q3	$22K	Hold	350	–	–	0.01%	288
2020 Q2	$27K	Buy	350 +160	+84%	+$12.3K	0.01%	251
2020 Q1	$14K	Buy	190 +40	+27%	+$2.76K	﹤0.01%	305
2019 Q4	$10K	Sell	150 -56	-27%	-$3.65K	﹤0.01%	420
2019 Q3	$13K	Buy	206 +56	+37%	+$3.66K	0.01%	331
2019 Q2	$10K	Hold	150	–	–	﹤0.01%	371
2019 Q1	$10K	Sell	150 -28	-16%	-$1.86K	﹤0.01%	382
2018 Q4	$11K	Sell	178 -350	-66%	-$24.5K	0.01%	363
2018 Q3	$41K	Sell	528 -154	-23%	-$11.6K	0.02%	236
2018 Q2	$48K	Hold	682	–	–	0.02%	216
2018 Q1	$51K	Hold	682	–	–	0.02%	205
2017 Q4	$49K	Sell	682 -73	-10%	-$5.54K	0.02%	206
2017 Q3	$61K	Sell	755 -75	-9%	-$5.74K	0.03%	188
2017 Q2	$59K	Buy	830 +126	+18%	+$8.38K	0.03%	187
2017 Q1	$48K	Buy	704 +100	+17%	+$7.03K	0.03%	207
2016 Q4	$43K	Sell	604 -42	-7%	-$3.12K	0.03%	219
2016 Q3	$51K	Buy	646 +22	+4%	+$1.79K	0.04%	186
2016 Q2	$52K	Sell	624 -6	-1%	-$532	0.04%	192
2016 Q1	$58K	Sell	630 -94	-13%	-$8.48K	0.04%	201
2015 Q4	$73K	Sell	724 -29	-4%	-$3.02K	0.05%	177
2015 Q3	$74K	Buy	753 +183	+32%	+$20.3K	0.06%	166
2015 Q2	$67K	Buy	570 +26	+5%	+$2.84K	0.05%	192
2015 Q1	$53K	Buy	544 +449	+473%	+$45.6K	0.04%	209
2014 Q4	$9K	Sell	95 -36	-27%	-$3.72K	0.01%	391
2014 Q3	$14K	Buy	131 +86	+191%	+$8.42K	0.01%	335
2014 Q2	$4K	Sell	45 -50	-53%	-$3.89K	﹤0.01%	467
2014 Q1	$7K	Sell	95 -50	-34%	-$3.92K	0.01%	426
2013 Q4	$11K	Buy	+145	New	+$10.1K	0.01%	361

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tradewinds Capital Management's GILD Position: Q2 2026 in Review

Tradewinds Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 40 shares worth $5.05K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Tradewinds Capital Management first reported a position in GILD in Q4 2013 and has held it in 51 quarters since. The position peaked at $74K in Q3 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Tradewinds Capital Management held 40 shares of Gilead Sciences worth $5.05K as of Q2 2026.
Tradewinds Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #469 holding.
Tradewinds Capital Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 51 quarters since.
Tradewinds Capital Management's Gilead Sciences position peaked at $74K in Q3 2015.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.